首页> 外文期刊>The Turkish journal of pediatrics >Generalized periosteal reaction and tissue swelling secondary to prolonged prostaglandin E1 infusion and venous stasis: A case report
【24h】

Generalized periosteal reaction and tissue swelling secondary to prolonged prostaglandin E1 infusion and venous stasis: A case report

机译:长期前列腺素E1输注和静脉淤滞继发的广泛性骨膜反应和组织肿胀:一例报告

获取原文
获取原文并翻译 | 示例
           

摘要

Prostaglandin E1 (PGE1) is the drug of choice for providing ductal patency in cyanotic congenital heart disease (CCHD) for a short period of time until essential surgical management. Occasionally, prolonged use of PGE1 is required when the surgical procedure is delayed due to certain clinical conditions. Prolonged use of PGE1 may lead to bone and tissue changes such as pretibial and soft tissue swelling of the extremities and reversible cortical proliferation of the bones. Venous stasis as an additional risk factor can result in generalized periosteal reaction that initially can cause the separation of the periosteum from the cortex. We report an infant with CCHD who developed severe tissue swelling and generalized periosteal reaction due to coexistence of prolonged use of PGE1 and venous stasis. To the best of our knowledge, this is the first case report with both of these risk factors.
机译:前列腺素E1(PGE1)是选择的药物,可在短时间内为紫otic性先天性心脏病(CCHD)提供导管通畅,直到进行必要的手术治疗为止。有时,由于某些临床情况而导致手术延迟时,需要长时间使用PGE1。长时间使用PGE1可能会导致骨骼和组织改变,例如四肢的胫前和软组织肿胀以及骨骼的可逆皮层增生。静脉淤滞是另一个危险因素,可导致广泛的骨膜反应,最初可引起骨膜与皮质的分离。我们报告了一名患有CCHD的婴儿,由于长期使用PGE1和静脉淤滞并存,其发生了严重的组织肿胀和广泛的骨膜反应。据我们所知,这是同时存在这两个风险因素的第一例病例报告。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号